Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Endokrine Kombinationstherapien beim lokal fortgeschrittenen, metastasierten Mammakarzinom – zusammen besser als allein
Translated title of the contribution
:
Endocrine combination therapies in locally advanced and metastatic breast cancer—combination therapy better than monotherapy
Carlota Claussen
*
,
Achim Rody
*
Corresponding author for this work
Clinic of Gynecology and Obstetrics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endocrine combination therapies in locally advanced and metastatic breast cancer—combination therapy better than monotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Breast Cancer
100%
Combination Therapy
100%
Metastatic Breast Cancer
100%
Monotherapy
100%
Hormone Therapy
50%
Hormone Receptor
50%
Everolimus
50%
Mechanistic Target of Rapamycin
50%
Phosphatidylinositide
50%
Exemestane
50%
Alpelisib
50%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Combination Therapy
100%
Breast Cancer
100%
Metastatic Breast Cancer
100%
Endocrine Therapy
50%
Mammalian Target of Rapamycin
50%
Cyclin Dependent Kinase 4
50%
Alpelisib
50%
Phosphatidylinositide
50%
Hormone Receptor
50%
Exemestane
50%